Manipal Health to add 483 licenced beds through brownfield and 1,943 licenced beds through greenfield projects by 2030

Manipal Health is committed to driving growth by capitalizing on opportunities within its existing network and expanding its footprint through both brownfield and greenfield projects. It seeks to maintain and strengthen its leadership in its key regions of Karnataka, Maharashtra and Goa, and eastern India (particularly West Bengal), while increasing its presence in regions such as Delhi NCR, central India, and eastern India (particularly Ranchi, Jharkhand, and Bhubaneswar, Odisha).

Through its brownfield expansion plans, the company expects to add approximately 483 licensed beds across existing hospitals by 2030. Brownfield projects benefit from operating leverage at established facilities and generally achieve faster break-even and require lower capital expenditure than greenfield projects. It is carrying out these expansions with the aim of strengthening our position in our existing markets. 

Its greenfield expansion plan is anchored in markets where it already operates such as Karnataka and Maharashtra to enable a faster ramp-up. The company plan to add approximately 1,943 licensed beds through these greenfield projects by 2030. it will continue to explore greenfield expansion opportunities in our key regions of Karnataka, Maharashtra and Goa and eastern India.

It also intends to capture medical tourism opportunities in key locations such as Bengaluru, Kolkata, and Delhi, and it intends to expand into Mumbai. South Asia accounts for over three-quarters of medical tourism demand, with majority of medical tourists coming from Africa, the Middle East, and South Asia as of calendar year 2025, and an increase in medical tourists from the United States and the United Kingdom due to high treatment costs and long waiting periods for availing treatment in these regions (Source: CRISIL Report). In Fiscal 2026, the company treated international patients primarily from the Middle East, Africa, and South Asia.

As of March 31, 2026, the company operated 49 hospitals with 13,037 licensed beds across 14 states and union territories. It has the widest footprint in terms of presence of hospitals among private hospital chains in India as of March 31, 2026 (Source: CRISIL Report).

Manipal Health Enterprises Ltd's Initial Public Offering is open between Wednesday, July 29, 2026, till Friday, July 31, 2026 with the Price Band set at ₹560 – ₹590 Per Equity Share.

Investors can bid for a minimum of 25 Equity Shares and in multiples of 25 Equity Shares thereafter.

Equity shares outstanding as on date 1,179,757,321 Equity Shares of ₹2 each.

The IPO is a fresh issue of up to Rs 8,000 crore, and an offer-for-sale of up to 21,613,834 equity shares by promoters - Imperius Healthcare Investments Pte. Ltd, and Manipal Education and Medical Group India Private Limited.

Manipal Health has garnered Rs 4,167 crore from anchor investors ahead of its initial public offering, which opens for public subscription on Wednesday, July 29, 2026. The company informed the bourses that it allocated 70,628,768 equity shares at Rs 590 per share to anchor investors. 

The anchor book saw the participation of marquee institutions such as ABU DHABI INVESTMENT AUTHORITY – STABLE, TEMPLETON EMERGING MARKETS FUND, BNP PARIBAS TRUST SERVICES SINGAPORE LIMITED AS TRUSTEE OF FULLERTON ALPHA - ASIA FOCUS EQUITIES FUND, GOVERNMENT PENSION FUND Global, ALLIANZ GLOBAL INVESTORS FUND - ALLIANZ INDIA EQUITY and FIDELITY SECURITIES FUND FIDELITY BLUE CHIP GROWTH K6 FUND, amongst others.